{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:00:29Z","timestamp":1775080829984,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1124\/jpet.103.058834","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T23:33:16Z","timestamp":1075246396000},"page":"694-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Potentiation of Carbon Tetrachloride Hepatotoxicity and Lethality in Type 2 Diabetic Rats"],"prefix":"10.1016","volume":"308","author":[{"given":"Sharmilee P.","family":"Sawant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur V.","family":"Dnyanmote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartik","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi B.","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Latendresse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harihara M.","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.058834_bib1","doi-asserted-by":"crossref","unstructured":"Albrink MJ (1974) Dietary and drug treatment of hyperlipidemia in diabetes. Diabetes 23: 913\u2013918.","DOI":"10.2337\/diab.23.11.913"},{"key":"10.1124\/jpet.103.058834_bib2","doi-asserted-by":"crossref","unstructured":"Andrade RJ, Lucena MI, and Rodriguez-Mendizabal M (1996) Hepatic injury caused by acarbose. Ann Intern Med 124: 931.","DOI":"10.7326\/0003-4819-124-10-199605150-00030"},{"key":"10.1124\/jpet.103.058834_bib3","unstructured":"Bailey CJ and Flatt PR (1991) Animal models of non-insulin dependent diabetes mellitus, in Textbook of Diabetes (Pickup J and Williams G eds) pp 228\u2013239, Blackwell Scientific, London, UK."},{"key":"10.1124\/jpet.103.058834_bib4","doi-asserted-by":"crossref","unstructured":"Ballet F (1977) Hepatotoxicity in drug development: detection, significance and solutions. J Hepatol 26: 26\u201336.","DOI":"10.1016\/S0168-8278(97)80494-1"},{"key":"10.1124\/jpet.103.058834_bib5","doi-asserted-by":"crossref","unstructured":"Burton K (1956) A study of the conditions and mechanisms of the diphenylamine reaction for positive colorimetric estimation of DNA. Biochem J 62: 315\u2013323.","DOI":"10.1042\/bj0620315"},{"key":"10.1124\/jpet.103.058834_bib6","unstructured":"Butterworth KR, Carpanini FMB, Dunnington D, Grasso P, and Pelling D (1978) The production of periportal necrosis by allyl alcohol in the rat. Br J Pharmacol 63: 353\u2013354."},{"key":"10.1124\/jpet.103.058834_bib7","unstructured":"Chang LO and Looney WB (1965) A biochemical and autoradiographic study of the in vivo utilization of tritiated thymidine in regenerating rat liver. Cancer Res 25: 1817\u20131822."},{"key":"10.1124\/jpet.103.058834_bib8","doi-asserted-by":"crossref","unstructured":"Chauveau J, Moule Y, and Roullier CH (1956) Isolation of pure and unaltered liver nuclei, morphology and biochemical composition. Exp Cell Res 11: 317\u2013321.","DOI":"10.1016\/0014-4827(56)90107-0"},{"key":"10.1124\/jpet.103.058834_bib9","doi-asserted-by":"crossref","unstructured":"Chipman JK, Kurukgy M, and Walker CH (1979) Comparative metabolism of a dieldrin analogue: hepatic microsomal systems as models for metabolism in the whole animal. Biochem Pharmacol 28: 69\u201375.","DOI":"10.1016\/0006-2952(79)90272-7"},{"key":"10.1124\/jpet.103.058834_bib10","doi-asserted-by":"crossref","unstructured":"Dincer Y, Akcay T, Alademir Z, and Ilkova H (2002) Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res 505: 75\u201381.","DOI":"10.1016\/S0027-5107(02)00143-4"},{"key":"10.1124\/jpet.103.058834_bib11","doi-asserted-by":"crossref","unstructured":"El-Serag HB and Everhart JE (2002) Diabetes increases the risk of acute hepatic failure. Gastroenterology 122: 1822\u20131828.","DOI":"10.1053\/gast.2002.33650"},{"key":"10.1124\/jpet.103.058834_bib12","doi-asserted-by":"crossref","unstructured":"Greenwell A, Foley JF, and Maronpot RR (1991) An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 59: 251\u2013256.","DOI":"10.1016\/0304-3835(91)90149-C"},{"key":"10.1124\/jpet.103.058834_bib13","doi-asserted-by":"crossref","unstructured":"Groop L, Forsblom C, and Lehtovirta M (1997) Characterization of the prediabetic state. Am J Hypertens 10: 172S\u2013180S.","DOI":"10.1016\/S0895-7061(97)00149-0"},{"key":"10.1124\/jpet.103.058834_bib14","doi-asserted-by":"crossref","unstructured":"Hanasono GK, Cote MG, and Plaa GL (1975) Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or streptozotocin diabetic rats. J Pharmacol Exp Ther 192: 592\u2013604.","DOI":"10.1016\/S0022-3565(25)30101-1"},{"key":"10.1124\/jpet.103.058834_bib15","doi-asserted-by":"crossref","unstructured":"Kraegen EW, James DE, Storlien LH, Burleigh KM, and Chisholm DJ (1986) In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29: 192\u2013198.","DOI":"10.1007\/BF02427092"},{"key":"10.1124\/jpet.103.058834_bib16","doi-asserted-by":"crossref","unstructured":"LeRoith D (2002) \u03b2-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med 113: 3S\u201311S.","DOI":"10.1016\/S0002-9343(02)01276-7"},{"key":"10.1124\/jpet.103.058834_bib17","doi-asserted-by":"crossref","unstructured":"Limaye PB, Apte UM, Shankar K, Bucci TJ, Warbritton A, and Mehendale HM (2003) Calpain released from dying hepatocytes mediates progression of acute liver injury by model hepatotoxicants. Toxicol Appl Pharmacol 191: 211\u2013226.","DOI":"10.1016\/S0041-008X(03)00250-3"},{"key":"10.1124\/jpet.103.058834_bib18","doi-asserted-by":"crossref","unstructured":"Lucas D, Farez C, Bardou LG, Vaisse J, Attali JR, and Valensi P (1998) Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam Clin Pharmacol 12: 553\u2013558.","DOI":"10.1111\/j.1472-8206.1998.tb00985.x"},{"key":"10.1124\/jpet.103.058834_bib19","doi-asserted-by":"crossref","unstructured":"Mak DH and Ko KM (1997) Alterations in susceptibility to carbon tetrachloride toxicity and hepatic antioxidant\/detoxification system in streptozotocin-induced short-term diabetic rats: effects of insulin and Schisandrin B treatment. Mol Cell Biochem 175: 225\u2013232.","DOI":"10.1023\/A:1006883919687"},{"key":"10.1124\/jpet.103.058834_bib20","doi-asserted-by":"crossref","unstructured":"Mangipudy RS, Chanda S, and Mehendale HM (1995) Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect 103: 260\u2013267.","DOI":"10.1289\/ehp.95103260"},{"key":"10.1124\/jpet.103.058834_bib21","doi-asserted-by":"crossref","unstructured":"Mangipudy RS, Rao PS, and Mehendale HM (1996) Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity. Environ Health Perspect 104: 744\u2013749.","DOI":"10.1289\/ehp.96104744"},{"key":"10.1124\/jpet.103.058834_bib22","doi-asserted-by":"crossref","unstructured":"Maritim AC, Moore BH, Sanders RA, and Watkins JB III (2000) Effect of melatonin on phase I and II biotransformation enzymes in streptozotocin-induced diabetic rats. Int J Toxicol 19: 277\u2013283.","DOI":"10.1080\/10915810050202088"},{"key":"10.1124\/jpet.103.058834_bib23","doi-asserted-by":"crossref","unstructured":"Mehendale HM and Klingensmith JS (1988) In vivo metabolism of CCl4 by rats pretreated with chlordecone, mirex, or phenobarbital. Toxicol Appl Pharmacol 93: 247\u2013256.","DOI":"10.1016\/0041-008X(88)90124-X"},{"key":"10.1124\/jpet.103.058834_bib24","doi-asserted-by":"crossref","unstructured":"Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhini S, Quiason SG, Philips NJ, and Brunt EM (1998) Troglitazone-induced hepatic failure leading to liver transplantation: a case report. Ann Intern Med 129: 38\u201341.","DOI":"10.7326\/0003-4819-129-1-199807010-00009"},{"key":"10.1124\/jpet.103.058834_bib25","doi-asserted-by":"crossref","unstructured":"Novak RF and Woodcroft KJ (2000) The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res (NY) 23: 267\u2013282.","DOI":"10.1007\/BF02975435"},{"key":"10.1124\/jpet.103.058834_bib26","doi-asserted-by":"crossref","unstructured":"Pascoe WS, Jenkins AB, Kusunoki M, and Storlien LH (1992) Insulin action and determinants of glycemia in a rat model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 208\u2013215.","DOI":"10.1007\/BF00400919"},{"key":"10.1124\/jpet.103.058834_bib27","doi-asserted-by":"crossref","unstructured":"Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, and Giroix MH (1991) \u03b2-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type 2 diabetes. Diabetes 40: 486\u2013491.","DOI":"10.2337\/diabetes.40.4.486"},{"key":"10.1124\/jpet.103.058834_bib28","doi-asserted-by":"crossref","unstructured":"Ramaiah SK, Apte U, and Mehendale HM (2000) Diet restriction as a protective mechanism in noncancer toxicity outcomes: a review. Int J Toxicol 19: 413\u2013424.","DOI":"10.1080\/109158100750058776"},{"key":"10.1124\/jpet.103.058834_bib29","doi-asserted-by":"crossref","unstructured":"Rao PS, Mangipudy RS, and Mehendale HM (1997) Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: a novel dose-response. Toxicology 118: 181\u2013193.","DOI":"10.1016\/S0300-483X(97)03617-2"},{"key":"10.1124\/jpet.103.058834_bib30","doi-asserted-by":"crossref","unstructured":"Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett TM, Gadbois TM, and Reaven GM (2000) A new rat model of Type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49: 1390\u20131394.","DOI":"10.1053\/meta.2000.17721"},{"key":"10.1124\/jpet.103.058834_bib31","unstructured":"Seifer S, Dayton S, Novic B, and Muntwyler E (1950) Estimation of glycogen with anthrone reagent. Arch Biochem 25: 191\u2013200."},{"key":"10.1124\/jpet.103.058834_bib32","doi-asserted-by":"crossref","unstructured":"Soni MG, Ramaiah SK, Mumtaz MM, Clewell H, and Mehendale HM (1999) Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology. Regul Toxicol Pharmacol 29: 165\u2013174.","DOI":"10.1006\/rtph.1998.1280"},{"key":"10.1124\/jpet.103.058834_bib33","doi-asserted-by":"crossref","unstructured":"Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, and Feinglos MN (1988) Diet-induced type II diabetes in C57BL\/6J mice. Diabetes 37: 1163\u20131167.","DOI":"10.2337\/diabetes.37.9.1163"},{"key":"10.1124\/jpet.103.058834_bib34","doi-asserted-by":"crossref","unstructured":"Wang T, Fonetenot RD, Soni MG, Bucci TJ, and Mehendale HM (2000) Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol Appl Pharmacol 166: 92\u2013100.","DOI":"10.1006\/taap.2000.8952"},{"key":"10.1124\/jpet.103.058834_bib35","doi-asserted-by":"crossref","unstructured":"Wang T, Shankar K, Ronis MJJ, and Mehendale HM (2001) Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality. Toxicol Appl Pharmacol 173: 27\u201337.","DOI":"10.1006\/taap.2001.9165"},{"key":"10.1124\/jpet.103.058834_bib36","doi-asserted-by":"crossref","unstructured":"Wang Z, Hall SD, Maya JF, Li L, Asghar A, and Gorski JC (2003) Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 55: 77\u201385.","DOI":"10.1046\/j.1365-2125.2003.01731.x"},{"key":"10.1124\/jpet.103.058834_bib37","doi-asserted-by":"crossref","unstructured":"Warram JH, Martin BC, Krolewski AS, Soeldner JS, and Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909\u2013915.","DOI":"10.7326\/0003-4819-113-12-909"},{"key":"10.1124\/jpet.103.058834_bib38","doi-asserted-by":"crossref","unstructured":"Watkins JB III, Sanders RA, and Beck LV (1988) The effect of long-term streptozotocin-induced diabetes on the hepatotoxicity of bromobenzene and carbon tetrachloride and hepatic biotransformation in rats. Toxicol Appl Pharmacol 93: 329\u2013338.","DOI":"10.1016\/0041-008X(88)90133-0"},{"key":"10.1124\/jpet.103.058834_bib39","doi-asserted-by":"crossref","unstructured":"Woodcroft KJ, Hafner MS, and Novak RF (2002) Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 35: 263\u2013273.","DOI":"10.1053\/jhep.2002.30691"},{"key":"10.1124\/jpet.103.058834_bib40","doi-asserted-by":"crossref","unstructured":"Yang SQ, Lin HZ, Mandal AK, Huang J, and Diehl AM (2001) Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 4: 694\u2013706.","DOI":"10.1053\/jhep.2001.28054"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524311735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524311735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.058834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:47:15Z","timestamp":1739998035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524311735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0022356524311735"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.058834","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiation of Carbon Tetrachloride Hepatotoxicity and Lethality in Type 2 Diabetic Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.058834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}